A novel mouse model of obstructive sleep apnea by bulking agent-induced tongue enlargement results in left ventricular contractile dysfunction.

<h4>Aims</h4>Obstructive sleep apnea (OSA) is a widespread disease with high global socio-economic impact. However, detailed pathomechanisms are still unclear, partly because current animal models of OSA do not simulate spontaneous airway obstruction. We tested whether polytetrafluoroeth...

Full description

Bibliographic Details
Main Authors: Simon Lebek, Philipp Hegner, Christian Schach, Kathrin Reuthner, Maria Tafelmeier, Lars Siegfried Maier, Michael Arzt, Stefan Wagner
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0243844
id doaj-e0cfb62000834f6189841a97ca8aa2d6
record_format Article
spelling doaj-e0cfb62000834f6189841a97ca8aa2d62021-03-04T12:58:32ZengPublic Library of Science (PLoS)PLoS ONE1932-62032020-01-011512e024384410.1371/journal.pone.0243844A novel mouse model of obstructive sleep apnea by bulking agent-induced tongue enlargement results in left ventricular contractile dysfunction.Simon LebekPhilipp HegnerChristian SchachKathrin ReuthnerMaria TafelmeierLars Siegfried MaierMichael ArztStefan Wagner<h4>Aims</h4>Obstructive sleep apnea (OSA) is a widespread disease with high global socio-economic impact. However, detailed pathomechanisms are still unclear, partly because current animal models of OSA do not simulate spontaneous airway obstruction. We tested whether polytetrafluoroethylene (PTFE) injection into the tongue induces spontaneous obstructive apneas.<h4>Methods and results</h4>PTFE (100 μl) was injected into the tongue of 31 male C57BL/6 mice and 28 mice were used as control. Spontaneous apneas and inspiratory flow limitations were recorded by whole-body plethysmography and mRNA expression of the hypoxia marker KDM6A was quantified by qPCR. Left ventricular function was assessed by echocardiography and ventricular CaMKII expression was measured by Western blotting. After PTFE injection, mice showed features of OSA such as significantly increased tongue diameters that were associated with significantly and sustained increased frequencies of inspiratory flow limitations and apneas. Decreased KDM6A mRNA levels indicated chronic hypoxemia. 8 weeks after surgery, PTFE-treated mice showed a significantly reduced left ventricular ejection fraction. Moreover, the severity of diastolic dysfunction (measured as E/e') correlated significantly with the frequency of apneas. Accordingly, CaMKII expression was significantly increased in PTFE mice and correlated significantly with the frequency of apneas.<h4>Conclusions</h4>We describe here the first mouse model of spontaneous inspiratory flow limitations, obstructive apneas, and hypoxia by tongue enlargement due to PTFE injection. These mice develop systolic and diastolic dysfunction and increased CaMKII expression. This mouse model offers great opportunities to investigate the effects of obstructive apneas.https://doi.org/10.1371/journal.pone.0243844
collection DOAJ
language English
format Article
sources DOAJ
author Simon Lebek
Philipp Hegner
Christian Schach
Kathrin Reuthner
Maria Tafelmeier
Lars Siegfried Maier
Michael Arzt
Stefan Wagner
spellingShingle Simon Lebek
Philipp Hegner
Christian Schach
Kathrin Reuthner
Maria Tafelmeier
Lars Siegfried Maier
Michael Arzt
Stefan Wagner
A novel mouse model of obstructive sleep apnea by bulking agent-induced tongue enlargement results in left ventricular contractile dysfunction.
PLoS ONE
author_facet Simon Lebek
Philipp Hegner
Christian Schach
Kathrin Reuthner
Maria Tafelmeier
Lars Siegfried Maier
Michael Arzt
Stefan Wagner
author_sort Simon Lebek
title A novel mouse model of obstructive sleep apnea by bulking agent-induced tongue enlargement results in left ventricular contractile dysfunction.
title_short A novel mouse model of obstructive sleep apnea by bulking agent-induced tongue enlargement results in left ventricular contractile dysfunction.
title_full A novel mouse model of obstructive sleep apnea by bulking agent-induced tongue enlargement results in left ventricular contractile dysfunction.
title_fullStr A novel mouse model of obstructive sleep apnea by bulking agent-induced tongue enlargement results in left ventricular contractile dysfunction.
title_full_unstemmed A novel mouse model of obstructive sleep apnea by bulking agent-induced tongue enlargement results in left ventricular contractile dysfunction.
title_sort novel mouse model of obstructive sleep apnea by bulking agent-induced tongue enlargement results in left ventricular contractile dysfunction.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2020-01-01
description <h4>Aims</h4>Obstructive sleep apnea (OSA) is a widespread disease with high global socio-economic impact. However, detailed pathomechanisms are still unclear, partly because current animal models of OSA do not simulate spontaneous airway obstruction. We tested whether polytetrafluoroethylene (PTFE) injection into the tongue induces spontaneous obstructive apneas.<h4>Methods and results</h4>PTFE (100 μl) was injected into the tongue of 31 male C57BL/6 mice and 28 mice were used as control. Spontaneous apneas and inspiratory flow limitations were recorded by whole-body plethysmography and mRNA expression of the hypoxia marker KDM6A was quantified by qPCR. Left ventricular function was assessed by echocardiography and ventricular CaMKII expression was measured by Western blotting. After PTFE injection, mice showed features of OSA such as significantly increased tongue diameters that were associated with significantly and sustained increased frequencies of inspiratory flow limitations and apneas. Decreased KDM6A mRNA levels indicated chronic hypoxemia. 8 weeks after surgery, PTFE-treated mice showed a significantly reduced left ventricular ejection fraction. Moreover, the severity of diastolic dysfunction (measured as E/e') correlated significantly with the frequency of apneas. Accordingly, CaMKII expression was significantly increased in PTFE mice and correlated significantly with the frequency of apneas.<h4>Conclusions</h4>We describe here the first mouse model of spontaneous inspiratory flow limitations, obstructive apneas, and hypoxia by tongue enlargement due to PTFE injection. These mice develop systolic and diastolic dysfunction and increased CaMKII expression. This mouse model offers great opportunities to investigate the effects of obstructive apneas.
url https://doi.org/10.1371/journal.pone.0243844
work_keys_str_mv AT simonlebek anovelmousemodelofobstructivesleepapneabybulkingagentinducedtongueenlargementresultsinleftventricularcontractiledysfunction
AT philipphegner anovelmousemodelofobstructivesleepapneabybulkingagentinducedtongueenlargementresultsinleftventricularcontractiledysfunction
AT christianschach anovelmousemodelofobstructivesleepapneabybulkingagentinducedtongueenlargementresultsinleftventricularcontractiledysfunction
AT kathrinreuthner anovelmousemodelofobstructivesleepapneabybulkingagentinducedtongueenlargementresultsinleftventricularcontractiledysfunction
AT mariatafelmeier anovelmousemodelofobstructivesleepapneabybulkingagentinducedtongueenlargementresultsinleftventricularcontractiledysfunction
AT larssiegfriedmaier anovelmousemodelofobstructivesleepapneabybulkingagentinducedtongueenlargementresultsinleftventricularcontractiledysfunction
AT michaelarzt anovelmousemodelofobstructivesleepapneabybulkingagentinducedtongueenlargementresultsinleftventricularcontractiledysfunction
AT stefanwagner anovelmousemodelofobstructivesleepapneabybulkingagentinducedtongueenlargementresultsinleftventricularcontractiledysfunction
AT simonlebek novelmousemodelofobstructivesleepapneabybulkingagentinducedtongueenlargementresultsinleftventricularcontractiledysfunction
AT philipphegner novelmousemodelofobstructivesleepapneabybulkingagentinducedtongueenlargementresultsinleftventricularcontractiledysfunction
AT christianschach novelmousemodelofobstructivesleepapneabybulkingagentinducedtongueenlargementresultsinleftventricularcontractiledysfunction
AT kathrinreuthner novelmousemodelofobstructivesleepapneabybulkingagentinducedtongueenlargementresultsinleftventricularcontractiledysfunction
AT mariatafelmeier novelmousemodelofobstructivesleepapneabybulkingagentinducedtongueenlargementresultsinleftventricularcontractiledysfunction
AT larssiegfriedmaier novelmousemodelofobstructivesleepapneabybulkingagentinducedtongueenlargementresultsinleftventricularcontractiledysfunction
AT michaelarzt novelmousemodelofobstructivesleepapneabybulkingagentinducedtongueenlargementresultsinleftventricularcontractiledysfunction
AT stefanwagner novelmousemodelofobstructivesleepapneabybulkingagentinducedtongueenlargementresultsinleftventricularcontractiledysfunction
_version_ 1714801017714900992